Yoshitaka Seki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.

Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.

Journal: Clinical epigenetics
Published: January 21, 2025

Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.

Plasma biomarkers for afatinib monotherapy in EGFR-mutated non-small cell lung cancer: Novel insights from companion genomics analysis of the EXTRA study.

Journal: Cancer treatment and research communications
Published: October 15, 2024

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment.

Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment.

Journal: Scientific reports
Published: May 17, 2024

Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.

Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.

Journal: Therapeutic advances in medical oncology
Published: February 10, 2023

Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study.

Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study.

Journal: Respiratory investigation
Published: June 18, 2022

Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia.

Association between serum ferritin level and decreased diffusion capacity 3 months after the onset of COVID-19 pneumonia.

Journal: PloS one
Published: March 27, 2022

Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.

Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.

Journal: Respiratory medicine
Published: August 06, 2021

Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab.

Allergic bronchopulmonary aspergillosis in a patient with ankylosing spondylitis treated with adalimumab.

Journal: Respirology case reports
Published: May 12, 2021

Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis.

Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis.

Journal: BMC pulmonary medicine
Published: July 09, 2020

Clinical utility of thoracoscopy in elderly tuberculous pleurisy patients under local anesthesia.

Clinical utility of thoracoscopy in elderly tuberculous pleurisy patients under local anesthesia.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: March 06, 2020

A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.

A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: March 07, 2019

Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma.

Long-lasting response to afatinib that persisted after treatment discontinuation in a case of EGFR-mutated lung adenocarcinoma.

Journal: BMJ case reports
Published: February 03, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026